Antipsychotic treatment: polypharmacy is better than monotherapy – PRO
Guidance for treatment of ADHD in adults
ADHD in adults
Functional recovery in depression: role of cognitive symptoms
Treatment of schizophrenia negative symptoms: Do we have an adequate solution?
Schizophrenia is a Myth with a Strong Genetic Component
Cybersuicide in young people: implications for suicide prevention
Identification and diagnosis of patients with TRD and Clinical pathways for patients with TRD
Clinical management of cognitive symptoms in depression
Dopamine receptor partial agonism: State of the art
Functional impairment in patients with major depressive disorder
Addressing patients’ needs across the spectrum of mood disorders
The validation of THINC-it™ Abstract
Can D2 partial agonists improve functioning in clinical practice?
Continuous treatment in schizophrenia: addressing the controversies
Redefining Treatment Goals for Difficult to Treat Depression
The EPA 2020 congress is going virtual